Cpwm LLC bought a new position in Nutrien Ltd (NYSE:NTR) during the third quarter, Holdings Channel reports. The firm bought 8,095 shares of the company’s stock, valued at approximately $467,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. 10 15 Associates Inc. boosted its stake in shares of Nutrien by 1.8% in the 2nd quarter. 10 15 Associates Inc. now owns 50,192 shares of the company’s stock worth $2,729,000 after buying an additional 897 shares during the last quarter. Morningstar Investment Services LLC boosted its stake in shares of Nutrien by 6.8% in the 2nd quarter. Morningstar Investment Services LLC now owns 14,693 shares of the company’s stock worth $799,000 after buying an additional 933 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its stake in shares of Nutrien by 28.4% in the 3rd quarter. Steward Partners Investment Advisory LLC now owns 4,344 shares of the company’s stock worth $251,000 after buying an additional 962 shares during the last quarter. Fairfield Bush & CO. boosted its stake in shares of Nutrien by 8.2% in the 2nd quarter. Fairfield Bush & CO. now owns 13,182 shares of the company’s stock worth $717,000 after buying an additional 1,000 shares during the last quarter. Finally, Hellman Jordan Management Co. Inc. MA boosted its stake in shares of Nutrien by 4.4% in the 2nd quarter. Hellman Jordan Management Co. Inc. MA now owns 23,746 shares of the company’s stock worth $1,291,000 after buying an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 66.70% of the company’s stock.
Nutrien stock opened at $51.73 on Friday. Nutrien Ltd has a 12 month low of $40.41 and a 12 month high of $58.99. The company has a market capitalization of $31.35 billion, a P/E ratio of 40.97, a PEG ratio of 1.84 and a beta of 0.75.
Nutrien (NYSE:NTR) last issued its earnings results on Monday, November 5th. The company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.03. Nutrien had a net margin of 1.74% and a return on equity of 12.95%. The business had revenue of $4.03 billion for the quarter, compared to analysts’ expectations of $3.83 billion. The business’s revenue was up 226.9% compared to the same quarter last year. As a group, equities analysts expect that Nutrien Ltd will post 2.65 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 17th. Shareholders of record on Monday, December 31st will be issued a dividend of $0.43 per share. This is a boost from Nutrien’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend is Friday, December 28th. This represents a $1.72 dividend on an annualized basis and a yield of 3.32%.
A number of equities analysts have recently weighed in on the company. Zacks Investment Research upgraded Nutrien from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a research note on Wednesday, August 15th. Barclays assumed coverage on Nutrien in a research note on Tuesday, September 4th. They issued an “overweight” rating and a $65.00 price objective on the stock. Cowen upped their price objective on Nutrien from $63.00 to $70.00 and gave the company an “outperform” rating in a research note on Thursday, August 9th. Royal Bank of Canada set a $65.00 price objective on Nutrien and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Finally, BMO Capital Markets reiterated a “hold” rating and issued a $55.00 price objective on shares of Nutrien in a research note on Wednesday, September 19th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Nutrien presently has a consensus rating of “Buy” and a consensus target price of $62.67.
ILLEGAL ACTIVITY WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/12/07/cpwm-llc-buys-new-position-in-nutrien-ltd-ntr.html.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Read More: Average Daily Trade Volume – What You Need to Know
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.